A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.

Wong, Jeffrey Y C

A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Dec 2003 - 5842-52 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S.; Review

1078-0432


Antibodies, Monoclonal--therapeutic use
Antimetabolites, Antineoplastic--therapeutic use
Carcinoembryonic Antigen--immunology
Colorectal Neoplasms--metabolism
Combined Modality Therapy
Feasibility Studies
Fluorouracil--therapeutic use
Humans
Maximum Tolerated Dose
Radioimmunotherapy
Recombinant Fusion Proteins--therapeutic use
Yttrium Radioisotopes--therapeutic use